{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:18:41Z","timestamp":1790014721662,"version":"4.0.1"},"reference-count":53,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2002,7,4]],"date-time":"2002-07-04T00:00:00Z","timestamp":1025740800000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2002,7]]},"abstract":"<jats:p>Oral fluids are rarely a vehicle for HIV\u20101 infection <jats:italic>in\u00a0vivo<\/jats:italic>, unlike other mucosal secretions. This unique property raises questions regarding (1) the molecular mechanisms responsible for the lack of salivary transmission, (2) the extent to which oral immunological responses mirror responses at other mucosal sites, (3) the use of promising salivary markers of HIV\u20101 disease progression, (4) the relationship between oral and blood viral loads, (5) cofactors that influence oro\u2010genital transmission, and (6) the feasibility of oral\u2010based antibody testing for HIV\u20101 diagnosis in the home. This paper discusses these questions and provides background summaries, findings from new studies, consensus opinions, practical relevance to developing countries, and suggestions for future research agenda on each of the key topics.<\/jats:p>","DOI":"10.1034\/j.1601-0825.8.s2.7.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T15:46:02Z","timestamp":1047483962000},"page":"169-175","source":"Crossref","is-referenced-by-count":38,"title":["Saliva and inhibition of HIV\u20101 infection: molecular mechanisms"],"prefix":"10.1111","volume":"8","author":[{"given":"DC","family":"Shugars","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SP","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Malamud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SH","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Page\u2010Shafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SJ","family":"Challacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,7,4]]},"reference":[{"key":"e_1_2_10_2_1","first-page":"184","article-title":"Role of neopterin and 7,8\u2010dihydroneopterin in human immunodeficiency virus infection: marker for disease progression and pathogenic link","volume":"13","author":"Baier\u2010Bitterlich G","year":"1996","journal-title":"J AIDS"},{"key":"e_1_2_10_3_1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1128\/CDLI.6.6.808-811.1999","article-title":"Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1\u2010infected patients","volume":"6","author":"Baqui AA","year":"1999","journal-title":"Clin Diag Laboratory Immunol"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.3.303"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001703-199810000-00005"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-1941-6_41"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00159-4"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1997.tb00381.x"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90208-3"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.62.3.892-896.1994"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4807861"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.6.1406"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01644476"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540270080030"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.1999.tb00367.x"},{"key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CDLI.7.3.515-518.2000","article-title":"Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell\u2010associated virus across tight epithelial barriers","volume":"7","author":"Hocini H","year":"2000","journal-title":"Clin Diag Laboratory Immunol"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.3.1602"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199901140-00004"},{"key":"e_1_2_10_19_1","unstructured":"KazmiS O'SheaS SweetSP BanatvalaJE ChallacombeSJ(1998). Evaluation of the HIV\u2010inhibitory activity of seven human mucosal fluids. International Conference on AIDS.12:516(Abstract. #31106)."},{"key":"e_1_2_10_20_1","unstructured":"KazmiSH SweetSP EvansR O'SheaS BanatvalaJE ChallacombeSJ(2002).Identification of the HIV\u20101\u2010specific inhibitory factors present in saliva. Submitted."},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/00220345980770070601"},{"key":"e_1_2_10_22_1","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.4049\/jimmunol.160.7.3194","article-title":"Differential susceptibility to activation\u2010induced apoptosis among peripheral Th1 subsets: correlation with Bcl\u20102 expression and consequences for AIDS pathogenesis","volume":"160","author":"Ledru E","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_10_23_1","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/clinchem\/34.6.1360a","article-title":"Increased IgA as a predictor of development of AIDS in HIV\u2010infected subjects","volume":"34","author":"Lefr\u00e8re J\u2010J","year":"1988","journal-title":"Clin Chem"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1086\/314809"},{"key":"e_1_2_10_25_1","first-page":"373","article-title":"Th1\/Th2 cytokine expression in saliva of HIV\u2010positive and HIV\u2010negative individuals: a pilot study in HIV\u2010positive individuals with oropharyngeal candidiasis","volume":"19","author":"Leigh J","year":"1998","journal-title":"J AIDS"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00032-6"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/000456329903600506"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118056"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-12-199706150-00003"},{"key":"e_1_2_10_30_1","first-page":"129","article-title":"Biology of disease: mucosal immunity, HIV transmission and AIDS","volume":"129","author":"Miller CJ","year":"1992","journal-title":"Laboratory Invest"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02415-6"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/16.2.301"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1997.13.371"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1086\/314511"},{"key":"e_1_2_10_35_1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1128\/CDLI.5.4.507-512.1998","article-title":"Oral fluids as an alternative to serum for measurement of markers of immune activation","volume":"5","author":"Nishanian P","year":"1998","journal-title":"Clin Diag Laboratory Immunol"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.2.566"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009311"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1999.0401"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)09185-X"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199816000-00004"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704103361507"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-4-199608150-00001"},{"issue":"1","key":"e_1_2_10_43_1","article-title":"Oral cavity as a potential HIV\u20101 reservoir: factors associated with salivary viral hyper\u2010secretion","volume":"8","author":"Shugars DC","year":"2002","journal-title":"Oral Dis"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1997.tb00379.x"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(00)70124-7"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1998.0349"},{"key":"e_1_2_10_47_1","first-page":"1","article-title":"Cellular immunology of HIV infection","volume":"71","author":"Spickett GP","year":"1988","journal-title":"Clin Exp Med"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)93237-J"},{"key":"e_1_2_10_49_1","article-title":"Salivary calprotectin levels are raised in patients with oral candidiasis or Sj\u00f6gren's syndrome but decreased by HIV infection","author":"Sweet SP","year":"2000","journal-title":"Oral Microbiol Immunol"},{"key":"e_1_2_10_50_1","first-page":"556","article-title":"IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva","volume":"86","author":"Sweet SP","year":"1995","journal-title":"Immunology"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199902040-00003"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010003"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1997.tb00377.x"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-199219020-00001"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1601-0825.8.s2.7.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1601-0825.8.s2.7.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1601-0825.8.s2.7.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T23:09:09Z","timestamp":1695769749000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1601-0825.8.s2.7.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":53,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["10.1034\/j.1601-0825.8.s2.7.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1601-0825.8.s2.7.x","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}